Início › Colite ulcerativa › Missouri
Ensaios clínicos de Colite ulcerativa em Missouri
17 estudos para Colite ulcerativa estão buscando participantes em locais em Missouri.
Cidades em Missouri
Texto oficial do estudo (Inglês)
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
- SSM Health Medical Group, Bridgeton
- GI Associates Research, LLC, Columbia
- Mid America Gastro Intestinal Consultants, Kansas City
- e mais 1
RecrutandoFase 4
Idades de 18 a 80 · Todos os sexos · Atualizado em 30 de set. de 2026 · NCT06581328A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
- Site US-006, St Louis
RecrutandoFase 2
Idades de 18 a 75 · Todos os sexos · Atualizado em 29 de set. de 2026 · NCT07845487Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
- Specialists In Gastroenterology /ID# 283939, St Louis
RecrutandoFase 2
Idades de 18 a 75 · Todos os sexos · Atualizado em 29 de set. de 2026 · NCT07697456A Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002)
- BVL Research - Kansas ( Site 1054), Liberty
RecrutandoFase 2
Idades de 18 a 75 · Todos os sexos · Atualizado em 28 de set. de 2026 · NCT07463183A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
- Washington University, St Louis
RecrutandoFase 2/3
Idades de 2 a 17 · Todos os sexos · Atualizado em 24 de set. de 2026 · NCT05076175Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Washington University School of Medicine, St Louis
RecrutandoFase 3
Idades de 18 a 70 · Todos os sexos · Atualizado em 24 de set. de 2026 · NCT06937086Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- Siteman Cancer Center at Saint Peters Hospital, City of Saint Peters
- Siteman Cancer Center at West County Hospital, Creve Coeur
- University Health Truman Medical Center, Kansas City
- e mais 6
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 23 de set. de 2026 · NCT03816345A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
- KAD Clinical Research, St Louis
RecrutandoFase 2
Idades de 18 a 80 · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT07483073A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
- Washington University School of Medicine, St Louis
RecrutandoFase 3
Idades de 2 a 19 · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT04844606LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
- KAD Clinical Research, St Louis
- Specialists in Gastroenterology, St Louis
RecrutandoFase 2
Idades de 18 a 80 · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT07415044A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
- Mid-America Gastro-Intestinal Consultants, Kansas City
- BVL Clinical Research, Liberty
- Washington University School of Medicine, St Louis
RecrutandoFase 4
Idades de 18 a 65 · Todos os sexos · Atualizado em 21 de set. de 2026 · NCT06095128A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- Gateway Gastroenterology - Site Number: 8400097, Chesterfield
- BVL Clinical Research - Site Number: 8400005, Liberty
RecrutandoFase 3
Idades de 16 a 80 · Todos os sexos · Atualizado em 15 de set. de 2026 · NCT07185009Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
- BVL Research - Kansas ( Site 0292), Liberty
RecrutandoFase 3
Todas as idades · Todos os sexos · Atualizado em 9 de set. de 2026 · NCT06651281An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- Gateway Gastroenterology - Site Number: 8400097, Chesterfield
- BVL Clinical Research - Site Number: 8400005, Liberty
RecrutandoFase 3
Idades de 16 a 80 · Todos os sexos · Atualizado em 20 de ago. de 2026 · NCT07184996BOOM-IBD2 Pivotal Clinical Trial
- Gateway GI Research (Objective Health), St Louis
Recrutando
Idades de 18 a 85 · Todos os sexos · Atualizado em 6 de ago. de 2026 · NCT06571669A Study to Investigate the Efficacy and Safety of SAR442970 in Adult Participants With Ulcerative Colitis
- Investigational Site Number: 8400014, St Louis
RecrutandoFase 2
Idades de 18 a 75 · Todos os sexos · Atualizado em 23 de abr. de 2026 · NCT06975722A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
- Mirador Therapeutics Selected Site, Bridgeton
- Mirador Therapeutics Selected Site, Kansas City
- Mirador Therapeutics Selected Site, Liberty
RecrutandoFase 2
Idades de 18 a 80 · Todos os sexos · Atualizado em 12 de mar. de 2026 · NCT07113522Fonte: ClinicalTrials.gov, dados obtidos em 1 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.